quinazolines has been researched along with Cytokine Release Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choudhir, G; Kumar, A; Mishra, A; Pathak, Y; Tripathi, V | 1 |
1 other study(ies) available for quinazolines and Cytokine Release Syndrome
| Article | Year |
|---|---|
Rifampicin and Letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico study.
Topics: Acetates; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Cytokines; Drug Repositioning; Humans; Molecular Docking Simulation; Quinazolines; Rifampin; SARS-CoV-2; Viral Proteases | 2021 |